Boston Scientific’s Promising Trial Outcomes and Market Expansion Drive Buy Rating
Boston Scientific (BSX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Marie ...
News Medical1d
Pittcon to make historic first appearance in Boston’s world-leading scientific hub
Pittcon 2025 in Boston: a landmark event uniting industry and academia to advance analytical chemistry and foster groundbreaking scientific collaboration.
Boston Scientific Corp. stock rises Wednesday, still underperforms market
Shares of Boston Scientific Corp. BSX advanced 1.30% to $96.89 Wednesday, on what proved to be an all-around great trading ...
Merit Medical Systems: Strong Financial Performance and Positive Outlook Justify Buy Rating
Needham analyst Michael Matson reiterated a Buy rating on Merit Medical Systems (MMSI – Research Report) today and set a price target of ...